CTOs on the Move

MedLearning

www.medlearning.com

 
MedLearning is a Hasbrouck Heights, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Affinity Health Plan

Affinity Health Plan is an independent, not-for-profit organization offering low cost, quality health care coverage to underserved New Yorkers. Its programs are sponsored by New York State and include Child Health Plus, Family Health Plus, Medicaid managed care, and Medicare. Founded in 1986, Affinity serves more than 275,000 members in New York City, Long Island, and the surrounding counties of Westchester, Rockland and Orange.

PaxeraHealth

PaxeraHealth (Formerly Paxeramed) is a leading healthcare solution developer based in Boston, MA. We develop a full range of medical imaging solutions including PACS, RIS, VNA, multi-modality workstations, mobile App viewers, patient portal, dental PACS, Vet PACS, advanced visualization, Patient engagement and enterprise solutions. Leveraging technology and staying at the forefront of new healthcare IT technological developments is a high priority for PaxeraHealth. The company develops the next generation medical imaging and Patient engagement technologies designed to automate clients` workflow, elevate patient care and cut healthcare costs.

TAKE Solutions

TAKE is an industry leader in providing the following services to Pharmaceutical companies such as: CDISC Services, where we offer the most effective data standardization solutions and consulting services. The OneClinical team under the leadership of a

Imed Software Corporation

Imed Software Corporation is a Lafayette, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Inspyr Therapeutics

Inspyr Therapeutics, Inc. is a biotechnology company focused on the development and commercialization of promising, new therapeutics. Our work is motivated by a commitment to innovation and helping patients. We combine our powerful insights and rigorous scientific methods to create new treatment options for patients.